Ghadirian Hesam, Shirani Mohamad, Ghazi-Mirsaeed Shahab, Mohebi Saleh, Alimohamadi Maysam
Department of Neurosurgery, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Asian J Neurosurg. 2018 Jan-Mar;13(1):93-95. doi: 10.4103/1793-5482.181130.
Pituitary apoplexy is a rare clinical presentation caused by infarction of the pituitary gland or adenoma with or without hemorrhage. Although pituitary apoplexy is usually spontaneous, one of the predisposing factors is treatment with dopamine agonists, especially bromocriptine. The occurrence of apoplexy during cabergoline therapy is reported much less frequently. In this article, we report a 34-year-old man with macroprolactinomas who developed sudden visual deterioration due to pituitary apoplexy 1 year after initiation of cabergoline therapy. He was treated via endoscopic trans-sphenoidal surgery and his visual status recovered dramatically.
垂体卒中是一种由垂体梗死或腺瘤伴或不伴出血引起的罕见临床表现。尽管垂体卒中通常是自发的，但诱发因素之一是使用多巴胺激动剂治疗，尤其是溴隐亭。卡麦角林治疗期间发生卒中的报道则少得多。在本文中，我们报告了一名34岁的大泌乳素瘤男性患者，在开始卡麦角林治疗1年后因垂体卒中出现突然的视力恶化。他接受了内镜经蝶窦手术治疗，视力状况显著恢复。
